tiprankstipranks
Annexon Biosciences (ANNX)
NASDAQ:ANNX
US Market
Holding ANNX?
Track your performance easily

Annexon Biosciences (ANNX) Financial Statements

847 Followers

Annexon Biosciences Financial Overview

Annexon Biosciences's market cap is currently ―. The company's EPS TTM is $-1.038; its P/E ratio is -4.97; Annexon Biosciences is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue---$ 1.60M-
Gross Profit---$ 400.00K$ 600.00K
EBIT$ -34.82M$ -29.61M$ -28.57M$ -30.01M$ -34.78M
EBITDA$ -33.95M$ -27.62M$ -28.03M$ -29.47M$ -34.24M
Net Income Common Stockholders$ -34.82M$ -29.61M$ -25.18M$ -27.89M$ -32.48M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 340.12M$ 368.70M$ 264.95M$ 259.72M$ 165.27M
Total Assets$ 378.78M$ 406.08M$ 304.07M$ 297.67M$ 203.82M
Total Debt$ 29.61M$ 30.20M$ 30.79M$ 31.36M$ 31.51M
Net Debt$ -310.51M$ -338.50M$ -234.16M$ -228.36M$ -133.76M
Total Liabilities$ 47.22M$ 45.01M$ 41.66M$ 47.12M$ 46.98M
Stockholders Equity$ 331.56M$ 361.08M$ 262.38M$ 250.56M$ 156.84M
Cash Flow-
Free Cash Flow$ -32.02M$ -21.71M$ -28.27M$ -23.48M$ -28.31M
Operating Cash Flow$ -32.02M$ -21.71M$ -28.27M$ -23.48M$ -28.29M
Investing Cash Flow$ -45.93M$ -96.58M$ -77.30M$ -2.18M$ 47.84M
Financing Cash Flow$ 175.00K$ 123.65M$ 32.41M$ 117.60M-
Currency in USD

Annexon Biosciences Earnings and Revenue History

Annexon Biosciences Debt to Assets

Annexon Biosciences Cash Flow

Annexon Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis